Endovenous laser ablation for saphenous vein insufficiency: long-term results

To present the long-term results of our 158 endovenous laser ablation (EVLA) procedures. Materials and methods: From June 2008 to December 2011, 158 patients (89 women, 69 men; mean age: 38.2 years, range: 27-65) were treated with EVLA for venous insufficiency in 192 lower limbs. All patients were symptomatic and the majority had a class 4 or higher clinical disease (CEAP classification). A 980-nm diode laser was used under general anesthesia combined with local tumescent anesthesia to deliver 100 to 140 laser applications along the course of the vein. Compression bandages were applied for 2 weeks postoperatively. Follow-up exams were done by Doppler ultrasound exam at 4 weeks, 6 months, 1 year, and 2 years. Results: A total of 192 great saphenous veins were ablated, achieving a 99% clinical success rate. Postoperative complications were mild and well tolerated. Of the 2 (1.0%) recanalized target veins, 2 were successfully treated with a second EVLA procedure. After 3 to 6 months of EVLA treatment, 99% of the patients had significant relief of their symptoms. All patients returned to normal activity within 2 days. Conclusion: EVLA for symptomatic saphenous vein incompetence is a minimally invasive and successful technique in resolving varicose veins and reducing symptoms.

Endovenous laser ablation for saphenous vein insufficiency: long-term results

To present the long-term results of our 158 endovenous laser ablation (EVLA) procedures. Materials and methods: From June 2008 to December 2011, 158 patients (89 women, 69 men; mean age: 38.2 years, range: 27-65) were treated with EVLA for venous insufficiency in 192 lower limbs. All patients were symptomatic and the majority had a class 4 or higher clinical disease (CEAP classification). A 980-nm diode laser was used under general anesthesia combined with local tumescent anesthesia to deliver 100 to 140 laser applications along the course of the vein. Compression bandages were applied for 2 weeks postoperatively. Follow-up exams were done by Doppler ultrasound exam at 4 weeks, 6 months, 1 year, and 2 years. Results: A total of 192 great saphenous veins were ablated, achieving a 99% clinical success rate. Postoperative complications were mild and well tolerated. Of the 2 (1.0%) recanalized target veins, 2 were successfully treated with a second EVLA procedure. After 3 to 6 months of EVLA treatment, 99% of the patients had significant relief of their symptoms. All patients returned to normal activity within 2 days. Conclusion: EVLA for symptomatic saphenous vein incompetence is a minimally invasive and successful technique in resolving varicose veins and reducing symptoms.

___

  • Min RJ, Zimmet SE, Isaacs MN. Endovenous laser treatment of the incompetent greater saphenous vein. J Vasc Interv Radiol 2001; 12: 1167–71.
  • Teruya TH, Ballard JL. New approaches for the treatment of varicose veins. Surg Clin North Am 2004; 84: 1397–417.
  • Wagner WH, Levin PM, Cossman V, Lauterbach SR, Cohen JL, Farber A. Early experience with radiofrequency ablation of the greater saphenous vein. Ann Vasc Surg. 2004; 18: 42–7.
  • Dietzek AM. Endovenous radiofrequency ablation for treatment of varicose veins. Vascular 2007; 15: 255–61.
  • Ünlü Y, Karapolat S, Erkut B. Multiple aneurysms of the left external jugular vein. Turk J Med Sci 2005; 35: 43–5.
  • Min RJ, Khilnani NM. Endovenous laser ablation of varicose veins. J Cardiovasc Surg 2005; 46: 395–405.
  • Merchant RF, Pichot O. Long-term outcomes of endovenous radiofrequency obliteration of saphenous reflux as a treatment for superficial venous insufficiency. Vasc Surgery 2005; 42: 502–
  • Almeida JA, Kaufman JA. Radiofrequency endovenous ClosureFAST versus laser ablation for the treatment of great saphenous reflux: a multicenter, single-blinded, randomized study. JVIR 2009; 20: 752–9.
  • Timperman PE, Sichlau M, Ryu RK. Greater energy delivery improves treatment success of endovenous laser treatment of incompetent saphenous veins. J Vasc Interv Radiol 2004; 15: 1061–3.
  • Dexter D, Kabnick L, Berland T, Jacobowitz G. Complications of endovenous laser. Phlebology 2012; 27 (Suppl 1): 40–5.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Hepatitis G virus and its prevalence and genotypes in patients with hepatitis B and C in Ahvaz, southwestern Iran

Javanmard DAVOD, Makvandi MANOOCHEHR, Hajiani ESKANDAR, Khalafkhany DAVOD, Samarbaf Zadeh REZA ALI

Effects of ethyl pyruvate administration on female rats’ pyramidal cells of cornu ammonis after brain ischemia: a stereological and histopathological study

Ayşe İKİNCİ, Ersan ODACI, Orhan BAŞ

Rapid identification of Aeromonas species in stool samples with chromogenic media and matrix-assisted laser desorption ionization time of flight mass spectrometry: an institutional experience

Işın AKYAR, Simge CAN

What would happen if neurovascular bundles were left behind in radical retropubic prostatectomy?

Olcay KANDEMİR, Bayram DOĞAN, Ziya AKBULUT, Durmuş Alparslan DEMİRCİ, Ali Fuat ATMACA, Abdullah Erdem CANDA, Mevlana Derya BALBAY

No major impact of insertion/deletion polymorphism of the angiotensin-converting enzyme gene on thyroid-associated ophthalmopathy

Seydi OKUMUŞ, Şeniz DEMİRYÜREK, Mehtap ÖZKUR, Erol COŞKUN

Do characteristics of seriously injured older adults differ from those of their younger counterparts in the emergency department?

Hüseyin ŞAHİN, Ayhan AKÖZ, Memet IŞIK, Mücahit EMET

Relationship between significant coronary artery disease and coronary artery anomalies

Alparslan BİRDANE, Hüseyin Uğur YAZICI, Yüksel AYDAR, Aydın NADİR, Utku ŞENOL, Abdurrahman TASAL, Ömer GÖKTEKİN, Necmi ATA

Measurement of the in-air output ratio for high-energy photon beams used in radiotherapy

Murugan APPASAMY, Sidonia Valas XAVIER, Thayalan KUPPUSAMY, Ramasubramanian VELAYUDHAM

A multicenter study of the application of Six Sigma management in clinical rational drug use via pharmacist intervention

Lidao BAO, Nan CHEN, Tao SHANG, Puyan FANG, Zhanping XU, Wenchang GUO, Yi WANG

JAK2 V617F mutation in Iranian patients with myeloproliferative neoplasms: clinical and laboratory findings

Behzad POOPAK, Majid FARSHDOUSTI HAGH, Najmaldin SAKI, Fazel ELAHI, Hamid REZVANI, Gelareh KHOSRAVIPOUR, Mohammad Ali JAHANGIRPOUR, Shirin BOLOURI, Tolou GOLKAR, Parviz FALAH